Free Trial

Adaptimmune Therapeutics (ADAP) Income Statement & Balance Sheet

$1.13
+0.12 (+11.88%)
(As of 05/31/2024 ET)

Adaptimmune Therapeutics Income Statement, Balance Sheet and Cash Flow Statement


This page (NASDAQ:ADAP) was last updated on 6/2/2024 by MarketBeat.com Staff

From Our Partners